Fastidious chemical decontamination after cyclophosphamide vial breakage in a compounding unit.


Journal

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
ISSN: 1477-092X
Titre abrégé: J Oncol Pharm Pract
Pays: England
ID NLM: 9511372

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 14 4 2020
medline: 8 1 2021
entrez: 14 4 2020
Statut: ppublish

Résumé

An important amount of cytotoxic drug may accumulate in the workplace following the breakage of a vial containing an anticancer drug. Thanks to the monthly monitoring of the surface contamination in our compounding unit, a strong increase of cyclophosphamide contamination was highlighted in the storage area following the breakage of the vial, despite application of the emergency procedure. This study presents an analysis of chemical decontamination in the context of massive contamination. Samples were taken on the floor and on the caster of a storage shelf where the vial broke. The residual contamination was measured with a liquid chromatography-mass spectrometry/mass spectrometry method. An admixture of 10

Identifiants

pubmed: 32281518
doi: 10.1177/1078155220915961
doi:

Substances chimiques

Antineoplastic Agents, Alkylating 0
Cyclophosphamide 8N3DW7272P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2038-2041

Auteurs

Ophélie Petit (O)

Institut de Pharmacie, CHU Lille, Lille, France.

Guillaume Saint-Lorant (G)

ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, CHU Lille, University of Lille, Lille, France.
Department of Pharmacy, CHU de Caen, Caen, France.

Michèle Vasseur (M)

Institut de Pharmacie, CHU Lille, Lille, France.
ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, CHU Lille, University of Lille, Lille, France.

Julie Boucher (J)

Institut de Pharmacie, CHU Lille, Lille, France.

Justin Courtin (J)

Institut de Pharmacie, CHU Lille, Lille, France.

Marine Pinturaud (M)

Institut de Pharmacie, CHU Lille, Lille, France.

Delphine Allorge (D)

Pôle de Biologie-Pathologie-Génétique, Unité Fonctionnelle de Toxicologie, CHU Lille, Lille, France.
EA-4483-IMPECS-IMPact de l'Environnement Chimique sur la Santé Humaine, University of Lille, Lille, France.

Bertrand Decaudin (B)

Institut de Pharmacie, CHU Lille, Lille, France.
ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, CHU Lille, University of Lille, Lille, France.

Nicolas Simon (N)

Institut de Pharmacie, CHU Lille, Lille, France.
ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, CHU Lille, University of Lille, Lille, France.

Pascal Odou (P)

Institut de Pharmacie, CHU Lille, Lille, France.
ULR 7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, CHU Lille, University of Lille, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH